Publikationen, an denen er mitarbeitet Antoni Castells (79)

2022

  1. Differentially Deregulated MicroRNAs as Novel Biomarkers for Neoplastic Progression in Ulcerative Colitis

    Clinical and translational gastroenterology, Vol. 13, Núm. 7, pp. e00489

  2. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

    Cancers, Vol. 14, Núm. 19

2021

  1. Exome sequencing of early-onset patients supports genetic heterogeneity in colorectal cancer

    Scientific Reports, Vol. 11, Núm. 1

  2. Germline and somatic whole‐exome sequencing identifies new candidate genes involved in familial predisposition to serrated polyposis syndrome

    Cancers, Vol. 13, Núm. 4, pp. 1-21

  3. Identification of lynch syndrome carriers among patients with small bowel adenocarcinoma

    Cancers, Vol. 13, Núm. 24

  4. Identification of new genes involved in germline predisposition to early-onset gastric cancer

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-14

2020

  1. Clinical and Pathological Characterization of Lynch-Like Syndrome

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 2, pp. 368-374.e1

  2. Colorectal cancer genetic variants are also associated with serrated polyposis syndrome susceptibility

    Journal of Medical Genetics, Vol. 57, Núm. 10, pp. 677-682

  3. Risk of cancer in family members of patients with lynch-like syndrome

    Cancers, Vol. 12, Núm. 8, pp. 1-12

  4. Using linkage studies combined with whole-exome sequencing to identify novel candidate genes for familial colorectal cancer

    International Journal of Cancer, Vol. 146, Núm. 6, pp. 1568-1577

  5. Validation of miR-1228-3p as housekeeping for microRNA analysis in liquid biopsies from colorectal cancer patients

    Biomolecules, Vol. 10, Núm. 1

  6. White-Light Endoscopy Is Adequate for Lynch Syndrome Surveillance in a Randomized and Noninferiority Study

    Gastroenterology, Vol. 158, Núm. 4, pp. 895-904.e1

2019

  1. Analysis of a 6-mirna signature in serum from colorectal cancer screening participants as non-invasive biomarkers for advanced adenoma and colorectal cancer detection

    Cancers, Vol. 11, Núm. 10

  2. Correction: Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer (Clinical and Translational Gastroenterology, (2019) 10, e-00031, 10.14309/ctg.0000000000000003)

    Clinical and Translational Gastroenterology

  3. Endoscopic surveillance after colonic polyps and colorrectal cancer resection. 2018 update

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 3, pp. 188-201

  4. High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome

    Endoscopy, Vol. 51, Núm. 2, pp. 142-151

  5. Identification of a Novel Candidate Gene for Serrated Polyposis Syndrome Germline Predisposition by Performing Linkage Analysis Combined With Whole-Exome Sequencing

    Clinical and translational gastroenterology, Vol. 10, Núm. 10, pp. e00100

  6. Integrated analysis of germline and tumor DNA identifies new candidate genes involved in familial colorectal cancer

    Cancers, Vol. 11, Núm. 3

  7. Novel circulating mirna signatures for early detection of pancreatic neoplasia

    Clinical and Translational Gastroenterology, Vol. 10, Núm. 4

2018

  1. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples

    Clinical Epigenetics, Vol. 10, Núm. 1